TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery MADISON, Wis. — Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based […]
Integrated Platform Enables up to 3X Higher Throughput for Antibody Discovery and Characterization; Joint Solution Addresses Growing Demand from AI Drug Design Companies, Pharma, and CROs PALO ALTO, CA and SPRINGFIELD, NJ – Gator Bio, a leader in biolayer interferometry (BLI) systems, and Hudson Lab Automation, Inc., a leading laboratory automation provider, today announced the availability […]
Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences MILFORD, Mass. — Waters Corporation (NYSE: WAT) (“Waters”) today announced it has completed […]
New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, […]
New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100% transfection efficiency and exogenous gene expression in dynamic suspension (3D) cultures. SEATTLE, WA & TELFORD, PA – Pluristyx, Inc., a leading provider of induced pluripotent stem cell (iPSC)-based technologies, and Solesis, a leader in biomaterials and […]
New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100% transfection efficiency and exogenous gene expression in dynamic suspension (3D) cultures. SEATTLE, WA & TELFORD, PA – Pluristyx, Inc., a leading provider of induced pluripotent stem cell (iPSC)-based technologies, and Solesis, a leader in biomaterials and […]
SUNNYVALE, Calif. — Integrated DNA Technologies (IDT), a global leader in genomics, today issued the following statement about the recent landmark federal legislation that marks a significant step towards Medicare coverage for FDA-approved multi-early cancer detection (MCED) tests. IDT President Ajay Gannerkote says, “IDT has been a driving force in supporting the development of multi‑cancer […]
Initiative will create one of the world’s largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research consortium uniting four leading UK institutions, will use the 10x Genomics Xenium […]
ViaTag™ Haloalkane Ligands streamline workflows in a wide range of colors with lower overall cost compared to other wash-intensive haloalkane ligands. FREMONT, CA — Biotium, a leading provider of innovative fluorescent reagents and kits for life science research, announces the release of a new line of bright fluorescent ligands designed for flexible labeling of HaloTag? self-labeling protein […]
Collaboration will allow high-throughput, multiplexed spatial profiling of solid tumors, paving the way for precision oncology CAMBRIDGE, MA – LifeCanvas Technologies announces a collaboration with the Laboratory of Systems Pharmacology (LSP) at Harvard Medical School, led by Professor Peter Sorger, to investigate solid tumor biology in 3D. The joint effort combines the LSP’s world-leading translational cancer biology expertise […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
